Filociclovir Is an Active Antiviral Agent against Ocular Adenovirus Isolates In Vitro and in the Ad5/NZW Rabbit Ocular Model

Presently, there is no FDA- or EMA-approved antiviral for the treatment of human adenovirus (HAdV) ocular infections. This study determined the antiviral activity of filociclovir (FCV) against ocular HAdV isolates in vitro and in the Ad5/NZW rabbit ocular model. The 50% effective concentrations (EC(...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pharmaceuticals (Basel)
Päätekijät: Romanowski, Eric G., Hussein, Islam T. M., Cardinale, Steven C., Butler, Michelle M., Morin, Lucas R., Bowlin, Terry L., Yates, Kathleen A., Shanks, Robert M. Q., Kowalski, Regis P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8066960/
https://ncbi.nlm.nih.gov/pubmed/33810229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14040294
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia